{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:55:25Z","timestamp":1762458925937},"reference-count":26,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.k10e-257","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T05:20:24Z","timestamp":1305782424000},"page":"647-655","source":"Crossref","is-referenced-by-count":18,"title":["High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH"],"prefix":"10.1507","volume":"58","author":[{"given":"Junko Miyamoto","family":"Igaki","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Tokyo 194-8533, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Koto","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Izawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ariyasu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Innovative Drug Research Laboratories, Kyowa Hakko Kirin Co., Ltd, Tokyo 194-8533, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Hospital, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. <i>Nat Genet<\/i> 26(3): 345-348.","DOI":"10.1038\/81664"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Feng, J. Q.; Ward, L. M.; Liu, S.; Lu, Y.; Xie, Y.; Yuan, B.; Yu, X.; Rauch, F.; Davis, S. I.; Zhang, S.; Rios, H.; Drezner, M. K.; Quarles, L. D.; Bonewald, L. F.; White, K. E (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. <i>Nature Genet<\/i> 38: 1310-1315.","DOI":"10.1038\/ng1905"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lorenz-Depiereux, B.; Bastepe, M.; Benet-Pages, A.; Amyere, M.; Wagenstaller, J.; Muller-Barth, U.; Badenhoop, K.; Kaiser, S. M.; Rittmaster, R. S.; Shlossberg, A. H.; Olivares, J. L.; Loris, C.; Ramos, F. J.; Glorieux, F.; Vikkula, M.; Juppner, H.; Strom, T. M. (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. <i>Nature Genet<\/i> 38: 1248-1250.","DOI":"10.1038\/ng1868"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. <i>Am J Hum Genet<\/i> 86(2): 267-272.","DOI":"10.1016\/j.ajhg.2010.01.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. <i>Am J Hum Genet<\/i> 86(2): 273-278.","DOI":"10.1016\/j.ajhg.2010.01.010"},{"key":"6","unstructured":"6. PHEX Locus database: www.phexdb.mcgill.ca"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, J &uuml; ppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. <i>Matrix Biol<\/i> 23(7): 421-432.","DOI":"10.1016\/j.matbio.2004.09.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL (2000) MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. <i>Genomics<\/i> 67(1): 54-68.","DOI":"10.1006\/geno.2000.6235"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R (2003) Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. <i>J Clin Invest <\/i>112(5): 785-794.","DOI":"10.1172\/JCI18563"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. White KE, Larsson TE, Econs MJ (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. <i>Endocr Rev<\/i> 27(3): 221-241.","DOI":"10.1210\/er.2005-0019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shaikh A, Berndt T, Kumar R (2008) Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. <i>Pediatr Nephrol<\/i> 23(8): 1203-2310.","DOI":"10.1007\/s00467-008-0751-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, J &uuml; ppner H, Jonsson KB (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. <i>Endocrinology<\/i> 145(7): 3087-3094.","DOI":"10.1210\/en.2003-1768"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. <i>J Bone Miner Res<\/i> 19(3): 429-435.","DOI":"10.1359\/JBMR.0301264"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. <i>J Clin Endocrinol Metab<\/i> 87(11): 4957-4960.","DOI":"10.1210\/jc.2002-021105"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. <i>Bone<\/i> 42(6): 1235-1239.","DOI":"10.1016\/j.bone.2008.02.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jonsson KB, ZahradnikR, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.<i> N Engl J Med<\/i> 348: 1656-1663.","DOI":"10.1056\/NEJMoa020881"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Razzaque MS (2009) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. <i>Nat Rev Endocrinol<\/i> 5(11): 611-619.","DOI":"10.1038\/nrendo.2009.196"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. <i>J Clin Endocrinol Metab<\/i> 90(3): 1519-1524.","DOI":"10.1210\/jc.2004-1039"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. <i>J Clin Endocrinol Metab<\/i> 91(8): 3144-3149.","DOI":"10.1210\/jc.2006-0021"},{"key":"20","unstructured":"20. Burnett SM, Gunawardene SC, Bringhurst FR, J &uuml; ppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. <i>J Bone Miner Res<\/i> 21(8): 1187-1196."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Perward F, Azam N, Zhang MYH, Yamashita T, Tenenhouse HS, Portale AA (2005). Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. <i>Endocrinology<\/i> 146: 5358-5364.","DOI":"10.1210\/en.2005-0777"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. <i>Biochem Biophys Res Commun<\/i> 398(3): 513-518.","DOI":"10.1016\/j.bbrc.2010.06.110"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.<i> J Clin Endocrinol Metab<\/i> 95(4): 1846-1850.","DOI":"10.1210\/jc.2009-1671"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. <i>J Bone Miner Res<\/i> 18(7): 1227-1234.","DOI":"10.1359\/jbmr.2003.18.7.1227"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ito N, Fukumoto S, Takeuchi Y, Yasuda T, Hasegawa Y, Takemoto F, Tajima T, Dobashi K, Yamazaki Y, Yamashita T, Fujita T (2005). Comparison of two assays for fibroblast growth factor (FGF)-23. <i>J Bone Miner Metab<\/i> 23(6): 435-440.","DOI":"10.1007\/s00774-005-0625-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-lenghth FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. <i>J Clin Endocrinol Metab<\/i> 87: 4957-4960.","DOI":"10.1210\/jc.2002-021105"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/8\/58_K10E-257\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T22:25:44Z","timestamp":1560205544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/8\/58_K10E-257\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-257","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}